Bode
June 29, 2023
Wellcome and the Bill & Melinda Gates Foundation have announced funding, to advance a tuberculosis (TB) vaccine candidate, M72/AS01E (M72), through a Phase III clinical trial. If proven effective, M72 could potentially become the first new vaccine to help prevent pulmonary TB, a form of active TB, in more...

